RhumbLine Advisers’s Eton Pharmaceutcials ETON Stock Holding History

RhumbLine Advisers’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$758K	Buy	30,726 +290	+1%	+$5.07K	﹤0.01%	2352
2025 Q4	$515K	Sell	30,436 -5,688	-16%	-$100K	﹤0.01%	2646
2025 Q3	$785K	Sell	36,124 -470	-1%	-$7.8K	﹤0.01%	2391
2025 Q2	$521K	Buy	+36,594	New	+$578K	﹤0.01%	2659
2021 Q2	–	Sell	-10,340	Closed	-$76K	–	3026
2021 Q1	$76K	Hold	10,340	–	–	﹤0.01%	2958
2020 Q4	$84K	Buy	+10,340	New	+$79.8K	﹤0.01%	2984
2020 Q3	–	Sell	-11,630	Closed	-$63K	–	2993
2020 Q2	$63K	Buy	+11,630	New	+$57.8K	﹤0.01%	3015

Other funds holding ETON

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

RhumbLine Advisers's ETON Position: Q1 2026 in Review

RhumbLine Advisers increased its Eton Pharmaceutcials (ETON) stake by 0.95% in Q1 2026, buying an estimated $5.07K and bringing the position to 30,726 shares worth $758K. The position accounts for ﹤0.01% of the portfolio, ranked #2352.

RhumbLine Advisers first reported a position in ETON in Q2 2020 and has held it in 7 quarters since. The position peaked at $785K in Q3 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

RhumbLine Advisers held 30,726 shares of Eton Pharmaceutcials worth $758K as of Q1 2026.
RhumbLine Advisers bought 290 Eton Pharmaceutcials shares in Q1 2026, an estimated $5.07K.
Eton Pharmaceutcials made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #2352 holding.
RhumbLine Advisers first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 7 quarters since.
RhumbLine Advisers's Eton Pharmaceutcials position peaked at $785K in Q3 2025.
116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.